ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,246 | 15,920 | 18,207 | 18,779 | 17,624 |
| Depreciation Amortization | 48,355 | 29,383 | 14,686 | 59,791 | 44,597 |
| Income taxes - deferred | -4,383 | 1,205 | 3,104 | -11,740 | -3,394 |
| Accounts receivable | 4,426 | -4,012 | -10,339 | 3,359 | -13,404 |
| Other Working Capital | -6,402 | -14,730 | -10,225 | 24,860 | -2,938 |
| Other Operating Activity | 14,407 | 7,917 | 2,836 | 23,910 | 31,734 |
| Operating Cash Flow | $48,157 | $35,683 | $18,269 | $118,959 | $74,219 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -328 | 4,484 | 8,933 | -8,868 | -6,589 |
| Net Acquisitions | -393,079 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -631 | N/A | 0 | -9,643 | -7,143 |
| Other Investing Activity | -631 | 0 | 0 | -9,643 | -7,143 |
| Investing Cash Flow | $-394,038 | $4,484 | $8,933 | $-18,511 | $-13,732 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 316,250 | -1,500 | -750 | N/A | N/A |
| Debt Issued | 325,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,788 | 3,596 | 2,591 | 89,551 | 87,582 |
| Common Stock Repurchased | -10,641 | -9,961 | -8,661 | -4,987 | -4,756 |
| Dividend Paid | -1,219 | -813 | -406 | -1,625 | -1,219 |
| Other Financing Activity | -364,326 | -12,500 | -12,500 | -15,500 | -2,250 |
| Financing Cash Flow | $269,852 | $-21,178 | $-19,726 | $67,439 | $79,357 |
| Exchange Rate Effect | -75 | N/A | 0 | N/A | N/A |
| Beginning Cash Position | 221,121 | 221,121 | 221,121 | 53,234 | 53,234 |
| End Cash Position | 145,017 | 240,110 | 228,597 | 221,121 | 193,078 |
| Net Cash Flow | $-76,104 | $18,989 | $7,476 | $167,887 | $139,844 |
| Free Cash Flow | |||||
| Operating Cash Flow | 48,157 | 35,683 | 18,269 | 118,959 | 74,219 |
| Capital Expenditure | -13,842 | -9,030 | -4,581 | -8,868 | -6,589 |
| Free Cash Flow | 34,315 | 26,653 | 13,688 | 110,091 | 67,630 |